Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.71 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA9 | Q16790 | 1/20 | 0.57 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.51 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.45 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.45 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29558763 | 1.00 | MAPT (0.71) | MAPTGAACA1CA2CA9 | |
| SCHEMBL756920 | 0.90 | MAPT (0.59) | MAPTGAACA1CA2CA9 | |
| SCHEMBL8374908 | 0.90 | MAPT (0.87) | MAPTGAACA1CA2CA9 | |
| SCHEMBL1754308 | 0.86 | AKR1C3 (0.58) | MAPTCA1CA2NPC1TSHR | |
| SCHEMBL7743794 | 0.85 | MAPT (0.52) | MAPTGAACA1CA2CA9 | |
| SCHEMBL10948187 | 0.85 | KEAP1 (0.63) | MAPTGAAMAPK14POLBNPC1 | |
| SCHEMBL3178977 | 0.84 | MAPT (0.77) | MAPTGAACA1CA2CA9 | |
| SCHEMBL29364222 | 0.84 | MAPT (0.77) | MAPTGAACA1CA2CA9 | |
| SCHEMBL3138398 | 0.84 | MAPT (0.77) | MAPTGAACA1CA2CA9 | |
| Benzene SCHEMBL28318261 | 0.84 | AKR1C3 (0.61) | MAPTGAAMAPK14NPC1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 369 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116947922-A | Synthesis process of pitavastatin intermediate | 江苏福瑞康泰药业有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-110606839-B | Green synthesis method of polysubstituted quinazoline derivative | 南方医科大学 | 2021-10-08 | — | — | CN | claimed |
| CN-109574863-B | Synthesis method of 2-amino-4' -fluoro-benzophenone | 安徽省庆云医药股份有限公司 | 2021-09-14 | — | — | CN | claimed |
| CN-107673982-B | Preparation method of 2-amino-4' -fluoro-benzophenone | 安徽省庆云医药股份有限公司 | 2020-07-24 | — | — | CN | claimed |
| CN-107652192-B | Method for preparing 2-amino-4' -fluoro-benzophenone | 安徽省庆云医药股份有限公司 | 2020-07-24 | — | — | CN | claimed |
| EP-3470491-A1 | PHOSPHORUS-CONTAINING STABILIZERS FOR FLUOROOLEFINS | The Chemours Company FC, LLC (US) | 2019-04-17 | — | — | EP | claimed |
| EP-2410032-B1 | Phosphorus-containing stabilizers for fluoroolefins | CHEMOURS CO FC LLC (US) | 2018-11-14 | — | — | EP | claimed |
| US-20170362483-A1 | EPOXIDE AND FLUORINATED EPOXIDE STABILIZERS FOR FLUOROOLEFINS | THE CHEMOURS COMPANY FC, LLC | 2017-12-21 | — | — | US | claimed |
| EP-2420546-B1 | Terephthalate stabilizers for fluoroolefins | CHEMOURS CO FC LLC (US) | 2017-04-26 | — | — | EP | claimed |
| EP-2598484-B1 | PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LEK PHARMACEUTICALS (SI) | 2016-06-29 | — | — | EP | claimed |
| WO-2008027519-A1 | OXETANE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027596-A2 | BENZOPHENONE DERIVATIVE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027512-A2 | FUNCTIONALIZED PERFLUOROPOLYETHER STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027594-A2 | PHENOL STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027518-A2 | ASCORBIC ACID, TEREPHTHALATE, OR NITROMETHANE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027513-A2 | ARYL-ALKYL ETHER, POLYOXYALKYLATED AROMATIC, AND ALKYLATED AROMATIC STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2007126760-A2 | COMPOSITIONS COMPRISING IODOTRIFLUOROMETHANE AND STABILIZERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-08 | — | — | WO | claimed |
| US-6841681-B2 | Process for producing quinoline carboxyaldehyde derivative and intermediate thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-01-11 | — | — | US | claimed |
| US-20040077866-A1 | Process for producing quinoline carboxyaldehyde derivative and intermediate thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2004-04-22 | — | — | US | claimed |
| EP-1361215-A1 | PROCESS FOR PRODUCING QUINOLINE CARBOXYALDEHYDE DERIVATIVE AND INTERMEDIATE THEREOF | Nissan Chemical Industries, Ltd. (JP) | 2003-11-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077866-A1 | Process for producing quinoline carboxyaldehyde derivative and intermediate thereof | CPNE4, CYP3A4, CYP4B1 | MAPT 2706/4885GAA 447/4885CA1 1949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.